MENU
OPHLY
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Ono Pharmaceutical (OPHLY) Ownership - Who owns Ono Pharmaceutical?

Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs... Show more

Profile

Industry
N/A
Address
8-2, Kyutaromachi 1-chome
Phone
+81 662635670
Employees
3555
Web
http://www.ono.co.jp

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
6.54B
P/E Ratio
19.27
Total Cash
182.93B
Projected Growth
N/A
Total Debt
130.42B
Revenue
503.67B
Risk (Beta)
0.20
Dividend Yield
0.04
Total Cash/Share
129.75
Total Debt/Equity
N/A
Revenue/Share
2.28 USD as % of share price

Fundamentals

OPHLY
Capitalization
6.54B
P/E Ratio
19.27
Risk (Beta)
0.20
Dividend Yield
0.04
Total Cash
183B
Total Cash/Share
129.75
Total Debt
130B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.28%
Revenue
504B
ROE
N/A
Book Value
806B
P/B Ratio
1.26
Cash Flow
N/A
Earnings
37.39
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
17.4B
Current Ratio
2.99
Current Revenue Per Employee
29267844.00
Dividends Per Share - Security
N/A
EBITDA
102B
Float
N/A
Float - Current
N/A
Gross Income Margin
71.92
Revenue To Assets
5.01
Shares Held By Institutions
1.12M
Shares Outstanding - Current
1.41B
Total Liabilities
247B
Total Volume MTD
N/A
Value
1
Gain YTD
32.385
View a ticker or compare two or three
OPHLY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. OPHLY showed earnings on October 30, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
8-2, Kyutaromachi 1-chome
Phone
+81 662635670
Employees
3555
Web
http://www.ono.co.jp